Immune-Inflammatory markers and heart failure incidence and mortality: a population-based longitudinal study - Takeaways - MDSpire

Immune-Inflammatory markers and heart failure incidence and mortality: a population-based longitudinal study

  • By

  • Siqi Li

  • Jie Cai

  • Feiyang Zhao

  • Liangkai Chen

  • Xia Han

  • Xue Xiao

  • Hui Xiong

  • Jinfeng Yang

  • June 11, 2026

  • 0 min

Share

  • 1

    Inflammation significantly contributes to heart failure (HF) development and prognosis, necessitating effective predictive biomarkers.

  • 2

    The study analyzed data from over 415,000 participants, comparing six immune-inflammatory indices for their predictive roles in HF.

  • 3

    The inflammatory burden index (IBI) showed the strongest association with HF risk, indicating an 86% higher risk in the highest quintile.

  • 4

    Higher levels of SIRI, AISI, IBI, and NLR correlated with increased all-cause mortality among HF patients, while CALLY indicated improved survival.

  • 5

    The IBI emerged as the most reliable biomarker for predicting HF incidence and mortality, highlighting its importance in risk stratification.

Original Source(s)

Immune-Inflammatory markers and heart failure incidence and mortality: a population-based longitudinal study

  • by Siqi Li, Jie Cai, Feiyang Zhao, Liangkai Chen, Xia Han, Xue Xiao, Hui Xiong, Jinfeng Yang

  • June 11, 2026

Related Content

Association of serum selenium levels with inflammatory and oxidative stress markers in patients with post-infarction heart failure: an exploratory case-control study supported by in vitro mechanistic evidence

Histopathological Assessment of Myocardial Ischemia-Reperfusion Injury Using Transformer-Based Artificial Intelligence: Model Comparison Study

ChatGPT response consistency to the 2025 ESC/EACTS guidelines for the management of valvular heart disease: A test–retest study using binary and multiple-choice questions